10-Q: Adtalem Global Education Reports Strong Q3 2025 Results, Driven by Enrollment Growth

Adtalem Global Education's Q3 2025 results showcase significant revenue and net income growth, fueled by increased enrollment across its Chamberlain, Walden, and Medical & Veterinary segments.

Summary

• Adtalem Global Education Inc. reported a 12.9% increase in revenue to $466.1 million for the third quarter of fiscal year 2025.
• Net income rose by 65.2% to $60.8 million compared to the same period last year.
• Diluted earnings per share increased by 71.0% to $1.59.
• Adjusted net income increased by 23.4% to $73.3 million.
• Diluted adjusted earnings per share increased by 28.0% to $1.92.
• Chamberlain University's total student enrollment increased by 8.7% and 6.8% for the January and March 2025 sessions, respectively.
• Walden University's total student enrollment increased by 13.5% as of March 31, 2025.
• The medical and veterinary schools experienced a 1.2% increase in total student enrollment for the January 2025 semester.
• A $100.0 million prepayment was made on the Term Loan B debt on January 17, 2025.
• Adtalem repurchased 791,420 shares of its common stock at an average cost of $98.06 per share during the quarter.
• The Board of Directors authorized a fifteenth share repurchase program for up to $150.0 million through May 6, 2028.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and enrollment growth. While there are some risks and challenges, the overall tone is optimistic and indicates a healthy business trajectory.

Positives

• Significant revenue growth of 12.9% indicates strong market demand for Adtalem's educational offerings.
• Substantial net income increase of 65.2% demonstrates improved profitability and operational efficiency.
• Enrollment growth across Chamberlain and Walden Universities signals successful student acquisition and retention strategies.
• Debt prepayment of $100 million strengthens the company's financial position and reduces interest expenses.
• Share repurchase programs indicate management's confidence in the company's future prospects and commitment to returning value to shareholders.

Negatives

• Medical and Veterinary segment operating income decreased 21.8%, or $5.0 million, to $17.8 million in the third quarter and decreased 8.8%, or $5.2 million, to $53.9 million in the first nine months of fiscal year 2025 compared to the prior year periods.
• The effective tax rate for the three and nine months ended March 31, 2025 increased compared to the prior year periods primarily due to an increase in the percentage of earnings from operations in higher taxed jurisdictions and a limitation of tax benefits on certain executive compensation.

Risks

• The company's financial results are subject to regulatory reviews and potential penalties.
• Changes in financial aid programs could restrict student eligibility or reduce funding levels, impacting Adtalem's financial condition.
• Failure to meet the 90/10 Rule could result in loss of eligibility to participate in Title IV programs.
• The new Gainful Employment rules could impact program eligibility and require warnings to students.
• The company's composite score declined to 0.2, requiring provisional certifications and heightened cash monitoring.

Future Outlook

Management anticipates full fiscal year 2025 capital spending to be in the $40 to $50 million range, primarily focused on information technology, new campus development at Chamberlain, and facility improvements at the medical and veterinary schools.

Industry Context

Adtalem's focus on healthcare education aligns with the growing demand for healthcare professionals, driven by an aging population and increasing healthcare needs. The company's online and hybrid learning models cater to working adults seeking flexible educational options, a trend that is reshaping the higher education landscape.

Comparison to Industry Standards

• Companies like Grand Canyon Education (LOPE) and Strategic Education (STRA) also operate in the for-profit education sector.
• Adtalem's revenue growth of 12.9% in Q3 2025 is competative with industry peers.
• Adtalem's focus on healthcare education provides a niche market compared to more diversified educational institutions.
• The company's investment in online learning platforms aligns with the industry's shift towards digital education.

Legal Proceedings

• Walden was served with a complaint alleging that it targeted, deceived, and exploited Black and female Doctor of Business Administration (DBA) students.
• Adtalem has previously disclosed DeVry University related matters that have consumed a portion of the Liability Cap.
• ED sent notice to Chamberlain, RUSM, RUSVM, and Walden that it had received borrower defense to repayment applications filed by students.

Stakeholder Impact

• Shareholders benefit from increased profitability and share repurchase programs.
• Students benefit from improved educational offerings and support services.
• Employees benefit from a stable and growing company.
• Creditors benefit from the company's strong financial position and debt repayment efforts.

Next Steps

• Continue to optimize investments in student enrollment and experience.
• Focus on increasing enrollment and renewing operational effectiveness in the medical and veterinary schools.
• Monitor and adapt to changes in financial aid programs and regulatory requirements.
• Execute the fifteenth share repurchase program to return value to shareholders.

Key Dates

Keywords

Adtalem Global Education, financial results, enrollment growth, revenue, net income, earnings per share, Chamberlain University, Walden University, medical schools, veterinary schools, debt prepayment, share repurchase, financial aid, 90/10 Rule, Gainful Employment